Health, Vaccines, Lyme Disease, FDA, Medicine.
disease: one that continues to focus on OspA and another targeting a different outer surface protein. Each takes a different approach in hopes of avoiding the mistakes of the past. Lyme disease cases have risen steadily in the United States over the past 20 years. Image credit: Centers for Disease